Enahoro Iboi

Pharmacometrician
Pfizer Inc.

Poster(s):

• (T-093) Adjusted Ideal Body Weight Dosing Reduces Pharmacokinetic Variability of the PD-L1 Targeted Antibody-Drug Conjugate PDL1V (PF-08046054)
  Tuesday, October 21, 2025

  7:00 AM - 1:45 PM MDT